UB Paderborn / Katalog / Suche / in CDI

Sortiert nach

Einfacher Volltextzugriff von (fast) überall

Installieren Sie die LibKey Nomad-Browsererweiterung und erhalten Sie von vielen Webseiten einfachen Zugriff auf lizenzierte Volltexte oder Open Access Publikationen. Mehr erfahren...

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study

Drug safety, 2024-08, Vol.47 (8), p.759-769

2024

Volltextzugriff (PDF)

Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes

Diabetes care, 2022-10, Vol.45 (10), p.2289-2298

2022

Volltextzugriff (PDF)

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials

Acta diabetologica, 2018-05, Vol.55 (5), p.503-514

2018

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes

Diabetes care, 2019-09, Vol.42 (9), p.e150-e152

2019

Volltextzugriff (PDF)

Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes

Clinical pharmacology and therapeutics, 2022-01, Vol.111 (1), p.272-282

2022

Volltextzugriff (PDF)

Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism

American journal of epidemiology, 2019-09, Vol.188 (9), p.1666-1673

2019

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes

Diabetes care, 2021-01, Vol.44 (1), p.e9-e11

2021

Volltextzugriff (PDF)

Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus

JAMA internal medicine, 2016-10, Vol.176 (10), p.1474

2016

Volltextzugriff (PDF)

Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

BMC medicine, 2023-02, Vol.21 (1), p.47-47, Article 47

2023

Volltextzugriff (PDF)

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

BMJ (Online), 2020-09, Vol.370, p.m3342

2020

Volltextzugriff (PDF)

Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study

Diabetes care, 2022-12, Vol.45 (12), p.2907-2917

2022

Volltextzugriff (PDF)

Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study

BMJ (Online), 2022-11, p.e071380

2022

Volltextzugriff (PDF)

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

BMJ (Online), 2018-12, Vol.363, p.k4880

2018

Volltextzugriff (PDF)

Pioglitazone use and risk of bladder cancer: population based cohort study

BMJ (Online), 2016-03, Vol.352, p.i1541

2016

Volltextzugriff (PDF)

Sodium‐glucose cotransporter‐2 inhibitors and the risk of lung cancer among patients with type 2 diabetes

British journal of clinical pharmacology, 2024-05, Vol.90 (5), p.1365-1370

2024

Volltextzugriff (PDF)

Glucagon like peptide-1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population-based cohort study

Diabetic medicine, 2024-04, Vol.41 (4), p.e15248-e15248

2024

Volltextzugriff (PDF)

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Pharmacoepidemiology and drug safety, 2024-10, Vol.33 (10), p.e70014-n/a

2024

Volltextzugriff (PDF)

Sodium‐glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population‐based cohort study

British journal of clinical pharmacology, 2023-09, Vol.89 (9), p.2902-2914

2023

Volltextzugriff (PDF)

Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population‐based cohort study

Diabetic medicine, 2023-08, Vol.40 (8), p.e15108-n/a

2023

Volltextzugriff (PDF)

Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies

Diabetes, obesity & metabolism, 2024-02, Vol.26 (2), p.721-731

2024

Volltextzugriff (PDF)

Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes

Cardiovascular diabetology, 2020-01, Vol.19 (1), p.12-12, Article 12

2020

Volltextzugriff (PDF)

Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study

Gut, 2023-05, Vol.72 (5), p.1020-1022

2023

Volltextzugriff (PDF)

Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population‐based cohort study

Diabetes, obesity & metabolism, 2023-06, Vol.25 (6), p.1523-1533

2023

Volltextzugriff (PDF)

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study

American journal of epidemiology, 2022-07, Vol.191 (8), p.1352-1367

2022

Volltextzugriff (PDF)

Response to: Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides

Clinical pharmacology and therapeutics, 2022-08, Vol.112 (2), p.203-203

2022

Volltextzugriff (PDF)

1 – 25 von 132

Suche als RSS-Feed

Suchergebnisse filtern

Filter anzeigen

Nur zeigen

Geprüft (Peer-Review)
(123)
Mit Volltextzugriff
(110)

Publikationsform

Sprache

Englisch
(132)

Erscheinungsjahr

n.n

Thema

Science & Technology
(96)
Life Sciences & Biomedicine
(94)
Humans
(67)
Diabetes
(51)
Diabetes Mellitus
(46)
Diabetes Mellitus, Type 2 - Drug Therapy
(41)
Endocrinology & Metabolism
(37)
Male
(37)
Female
(35)
Cohort Studies
(31)
Middle Aged
(28)
Aged
(27)
Hypoglycemic Agents - Adverse Effects
(27)
Cohort Analysis
(25)
Population Studies
(23)
United Kingdom - Epidemiology
(21)
Patients
(19)
Risk Factors
(19)
Type 2 Diabetes
(19)
Diabetes Mellitus, Type 2 - Epidemiology
(18)

15 weitere anzeigen...

Weniger anzeigen...

Neu hinzugefügt

... seit 30 Tagen
(1)
... seit 90 Tagen
(4)

Menü

Weitere Dienste

Einstellungen

Dipeptidyl Peptidase-4 Inhibitors and the Risk of Gallbladder and Bile Duct Disease Among Patients with Type 2 Diabetes: A Population-Based Cohort Study

Incretin-Based Drugs and the Risk of Acute Liver Injury Among Patients With Type 2 Diabetes

SGLT-2 inhibitors and the risk of infections: a systematic review and meta-analysis of randomized controlled trials

Sodium-Glucose Cotransporter 2 Inhibitors and the Risk of Fractures Among Patients With Type 2 Diabetes

Incretin‐Based Drugs and Risk of Intestinal Obstruction Among Patients With Type 2 Diabetes

Testosterone Replacement Therapy and the Risk of Prostate Cancer in Men With Late-Onset Hypogonadism

Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Breast Cancer Among Women With Type 2 Diabetes

Association of Bile Duct and Gallbladder Diseases With the Use of Incretin-Based Drugs in Patients With Type 2 Diabetes Mellitus

Association of adverse respiratory events with sodium-glucose cotransporter 2 inhibitors versus dipeptidyl peptidase 4 inhibitors among patients with type 2 diabetes in South Korea: a nationwide cohort study

Sodium glucose cotransporter 2 inhibitors and risk of major adverse cardiovascular events: multi-database retrospective cohort study

Sodium-Glucose Cotransporter 2 Inhibitors and the Short-term Risk of Bladder Cancer: An International Multisite Cohort Study

Novel antihyperglycaemic drugs and prevention of chronic obstructive pulmonary disease exacerbations among patients with type 2 diabetes: population based cohort study

Incretin based drugs and risk of cholangiocarcinoma among patients with type 2 diabetes: population based cohort study

Pioglitazone use and risk of bladder cancer: population based cohort study

Sodium‐glucose cotransporter‐2 inhibitors and the risk of lung cancer among patients with type 2 diabetes

Glucagon like peptide-1 receptor agonists and the risk of skin cancer among patients with type 2 diabetes: Population-based cohort study

The Prevalent New‐User Design to Study Drug–Drug Interactions: The Example of Sulfonylureas and Warfarin Interaction on the Risk of Severe Hypoglycemia

Sodium‐glucose cotransporter 2 inhibitors and the risk of venous thromboembolism: A population‐based cohort study

Use of metformin and insulin among pregnant women with gestation diabetes in the United Kingdom: A population‐based cohort study

Incretin-based drugs and the risk of diabetic retinopathy among individuals with type 2 diabetes: A systematic review and meta-analysis of observational studies

Polygenic risk for coronary heart disease acts through atherosclerosis in type 2 diabetes

Hepatic events associated with sodium-glucose cotransporter-2 inhibitors in patients with type 2 diabetes: a nationwide cohort study

Sulphonylureas versus metformin and the risk of ventricular arrhythmias among people with type 2 diabetes: A population‐based cohort study

Glucagon-Like Peptide 1 Receptor Agonists and Risk of Anaphylactic Reaction Among Patients With Type 2 Diabetes: A Multisite Population-Based Cohort Study

Response to: Real‐World Data on the Risk of Ventricular Arrhythmias with Sulfonamides

Suchergebnisse filtern